← FDA DRUG APPROVALS

FDA ANDA · ANDA209996

DESONIDE

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA209996
TYPE
ANDA
ORIGINAL APPROVAL
2017-09-15
LATEST ACTION
2017-09-15
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

DESONIDEDiscontinued
DESONIDE 0.05% · OINTMENT · TOPICAL

Approval history

2017-09-15UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →